AU1216988A - Immunogenic fusion proteins which contain Epstein-Barr virus protein - Google Patents

Immunogenic fusion proteins which contain Epstein-Barr virus protein

Info

Publication number
AU1216988A
AU1216988A AU12169/88A AU1216988A AU1216988A AU 1216988 A AU1216988 A AU 1216988A AU 12169/88 A AU12169/88 A AU 12169/88A AU 1216988 A AU1216988 A AU 1216988A AU 1216988 A AU1216988 A AU 1216988A
Authority
AU
Australia
Prior art keywords
fusion proteins
barr virus
virus protein
immunogenic fusion
epstein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU12169/88A
Other versions
AU609779B2 (en
Inventor
Harald Boos
Michael Broker
Nikolaus Muller-Lantzsch
Micha Nublich
Wilhelm Schuy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG filed Critical Behringwerke AG
Publication of AU1216988A publication Critical patent/AU1216988A/en
Application granted granted Critical
Publication of AU609779B2 publication Critical patent/AU609779B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU12169/88A 1987-02-26 1988-02-25 Immunogenic fusion proteins which contain epstein-barr virus protein Expired - Fee Related AU609779B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873706233 DE3706233A1 (en) 1987-02-26 1987-02-26 IMMUNOGENIC FUSION PROTEINS CONTAINING EPSTEIN BARR VIRUS PROTEINS
DE3706233 1987-02-26

Publications (2)

Publication Number Publication Date
AU1216988A true AU1216988A (en) 1988-09-01
AU609779B2 AU609779B2 (en) 1991-05-09

Family

ID=6321849

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12169/88A Expired - Fee Related AU609779B2 (en) 1987-02-26 1988-02-25 Immunogenic fusion proteins which contain epstein-barr virus protein

Country Status (4)

Country Link
EP (1) EP0281803A1 (en)
JP (1) JPS63248387A (en)
AU (1) AU609779B2 (en)
DE (1) DE3706233A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04310861A (en) * 1991-04-09 1992-11-02 Kazuo Yanagi Method and kit for measuring anti-ebna antibody
AU674936B2 (en) * 1993-02-23 1997-01-16 Theratech, Inc. Recombinant Epstein-Barr viral capsid antigen useful in diagnostic method
DE19526384C2 (en) * 1995-07-19 1997-07-10 Biotest Ag Recombinant autologous fusion proteins of the Epstein-Barr virus, as well as test kits containing them for the detection of Epstein-Barr virus-specific antibodies
CN111690056B (en) * 2020-04-30 2021-12-21 清华大学 Monoclonal antibody for neutralizing EB virus and application thereof
CN111548411B (en) * 2020-04-30 2022-03-29 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） Monoclonal antibody for neutralizing EB virus and application thereof
CN111574621B (en) * 2020-04-30 2022-03-29 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） Monoclonal antibody for neutralizing EB virus and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL70704A0 (en) * 1983-01-19 1984-04-30 Amgen Methods and materials for development of parvovirus vaccines
US4707358A (en) * 1984-01-30 1987-11-17 The University Of Chicago Vaccine against Epstein-Barr Virus
DE3572843D1 (en) * 1984-05-24 1989-10-12 Merck & Co Inc Site-specific proteolysis by renin
DE3583564D1 (en) * 1984-08-23 1991-08-29 Hans Joachim Wolf DNA SEQUENCES OF THE EBV GENOME, RECOMBINANT DNA MOLECULES, METHOD FOR THE PRODUCTION OF EBV-RELATED ANTIGENS, DIAGNOSTIC COMPOSITIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME ANTIGENS.
NZ220645A (en) * 1986-06-20 1989-10-27 Merck & Co Inc Modified varicella-zoster virus and its cultivation
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse

Also Published As

Publication number Publication date
DE3706233A1 (en) 1988-09-08
JPS63248387A (en) 1988-10-14
EP0281803A1 (en) 1988-09-14
AU609779B2 (en) 1991-05-09

Similar Documents

Publication Publication Date Title
AU1628895A (en) Recombinant virus
AU1365788A (en) Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins
AU4382193A (en) BPI-immunoglobulin fusion proteins
EP0324647A3 (en) Vector for the expression of fusion proteins and protein immunogens
AU2608292A (en) Human immunoglobulins produced by recombinant dna techniques
AU1539697A (en) Expression system of heterologous antigens as fusion proteins
AU4325089A (en) Viral vaccines
AU1072988A (en) Anticoagulant peptides
AU1466188A (en) Bifunctional proteins
AU3006789A (en) Expression of hiv binding proteins
AU4754490A (en) Heat-labile toxin b subunit fusion proteins
AU6979287A (en) Fusion proteins
AU575725B2 (en) Improved protein hydrolysate
AU1180088A (en) Protein extracts
AU1216988A (en) Immunogenic fusion proteins which contain Epstein-Barr virus protein
AU3597089A (en) Method for producing nonhyperglycosylated hepatitis b virus proteins
GB8815135D0 (en) Proteins & nucleic acids
AU3804589A (en) Novel proteins
AU5006990A (en) Milled proteins
AU2117388A (en) Recombinant htlv-iii proteins and uses thereof
AU3804689A (en) Modified proteins
AU6104786A (en) Fusion proteins using trple gene
AU7492087A (en) Newcastle disease virus protein
AU1676288A (en) Human immunodeficiency virus gag-encoded proteins
AU7440391A (en) Method for enhancing recovery of recombinant proteins